China · Delayed Price · Currency is CNY Hybio Pharmaceutical Statistics
Total Valuation
SHE:300199 has a market cap or net worth of CNY 18.60 billion. The enterprise value is 20.40 billion.
| Market Cap | 18.60B |
| Enterprise Value | 20.40B |
Important Dates
The last earnings date was Thursday, October 30, 2025.
| Earnings Date | Oct 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SHE:300199 has 883.24 million shares outstanding. The number of shares has increased by 2.68% in one year.
| Current Share Class | 883.24M |
| Shares Outstanding | 883.24M |
| Shares Change (YoY) | +2.68% |
| Shares Change (QoQ) | -9.28% |
| Owned by Insiders (%) | 24.64% |
| Owned by Institutions (%) | 3.63% |
| Float | 641.44M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 20.71 |
| PB Ratio | 27.93 |
| P/TBV Ratio | 49.51 |
| P/FCF Ratio | 144.32 |
| P/OCF Ratio | 53.55 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 70.43, with an EV/FCF ratio of 158.31.
| EV / Earnings | -302.29 |
| EV / Sales | 22.72 |
| EV / EBITDA | 70.43 |
| EV / EBIT | 140.64 |
| EV / FCF | 158.31 |
Financial Position
The company has a current ratio of 0.37, with a Debt / Equity ratio of 2.89.
| Current Ratio | 0.37 |
| Quick Ratio | 0.16 |
| Debt / Equity | 2.89 |
| Debt / EBITDA | 6.65 |
| Debt / FCF | 14.95 |
| Interest Coverage | 5.36 |
Financial Efficiency
Return on equity (ROE) is -10.67% and return on invested capital (ROIC) is 3.50%.
| Return on Equity (ROE) | -10.67% |
| Return on Assets (ROA) | 2.88% |
| Return on Invested Capital (ROIC) | 3.50% |
| Return on Capital Employed (ROCE) | 8.77% |
| Revenue Per Employee | 867,726 |
| Profits Per Employee | -65,214 |
| Employee Count | 1,035 |
| Asset Turnover | 0.29 |
| Inventory Turnover | 1.50 |
Taxes
In the past 12 months, SHE:300199 has paid 27.30 million in taxes.
| Income Tax | 27.30M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +77.27% in the last 52 weeks. The beta is 0.68, so SHE:300199's price volatility has been lower than the market average.
| Beta (5Y) | 0.68 |
| 52-Week Price Change | +77.27% |
| 50-Day Moving Average | 24.01 |
| 200-Day Moving Average | 17.38 |
| Relative Strength Index (RSI) | 44.95 |
| Average Volume (20 Days) | 54,095,944 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300199 had revenue of CNY 898.10 million and -67.50 million in losses. Loss per share was -0.08.
| Revenue | 898.10M |
| Gross Profit | 494.03M |
| Operating Income | 145.08M |
| Pretax Income | -47.20M |
| Net Income | -67.50M |
| EBITDA | 288.88M |
| EBIT | 145.08M |
| Loss Per Share | -0.08 |
Balance Sheet
The company has 140.42 million in cash and 1.93 billion in debt, giving a net cash position of -1.79 billion or -2.02 per share.
| Cash & Cash Equivalents | 140.42M |
| Total Debt | 1.93B |
| Net Cash | -1.79B |
| Net Cash Per Share | -2.02 |
| Equity (Book Value) | 666.08M |
| Book Value Per Share | 0.76 |
| Working Capital | -951.59M |
Cash Flow
In the last 12 months, operating cash flow was 347.34 million and capital expenditures -218.45 million, giving a free cash flow of 128.89 million.
| Operating Cash Flow | 347.34M |
| Capital Expenditures | -218.45M |
| Free Cash Flow | 128.89M |
| FCF Per Share | 0.15 |
Margins
Gross margin is 55.01%, with operating and profit margins of 16.15% and -7.52%.
| Gross Margin | 55.01% |
| Operating Margin | 16.15% |
| Pretax Margin | -5.26% |
| Profit Margin | -7.52% |
| EBITDA Margin | 32.17% |
| EBIT Margin | 16.15% |
| FCF Margin | 14.35% |
Dividends & Yields
SHE:300199 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.68% |
| Shareholder Yield | -2.68% |
| Earnings Yield | -0.36% |
| FCF Yield | 0.69% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 14, 2015. It was a forward split with a ratio of 2.
| Last Split Date | Apr 14, 2015 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |